These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8928353)

  • 1. [Essential phospholipids in the treatment of chronic pyelonephritis].
    Ovchinnikov AA; Tsvettsikh VE; Berdichevskiĭ BA; Lykov VN; Suktanbaev VR; Murychev AV
    Urol Nefrol (Mosk); 1996; (4):7-9. PubMed ID: 8928353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lipid peroxidation in patients with nephrolithiasis and chronic pyelonephritis in the remission stage].
    Golovanov SA; Drozhzheva VV
    Urol Nefrol (Mosk); 1995; (2):21-2. PubMed ID: 7785114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipid peroxidation in the kidney tissue of patients with nephrolithiasis and chronic pyelonephritis].
    Golod EA; Darenkov AF; Kirpatovskiĭ VI; Ianenko EK
    Urol Nefrol (Mosk); 1995; (5):8-10. PubMed ID: 8571492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antioxidant and membranoprotector treatment of chronic pyelonephritis].
    Gordiushina IV; Savchenko RP; Sukhanov DS; Petrov AIu; Romantsov MG
    Eksp Klin Farmakol; 2011; 74(4):27-30. PubMed ID: 21678656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipid peroxidation in patients with hypertension and chronic pyelonephritis with arterial hypertension].
    Siurin AA; Kulagin IuI; Kuznetsov NS; Prokhoda AF; Gets NP; Vyborova VA
    Klin Med (Mosk); 1990 Dec; 68(12):20-2. PubMed ID: 2084329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipid peroxidation and transmembrane transport in patients with chronic pyelonephritis].
    Tsvettsikh VE
    Urol Nefrol (Mosk); 1989; (6):31-4. PubMed ID: 2617735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipid peroxidation and Ca-dependent ATPase activity in the microsomal fraction of renal tissue in patients with nephrolithiasis and chronic pyelonephritis].
    Golod EA
    Urol Nefrol (Mosk); 1996; (5):14-6. PubMed ID: 9054096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Membrane-destabilizing processes as the universal basis of inflammation].
    Tsvettsik VE; Rodoman VE; Zhmurov VA; Krylov VI; Lerner GIa; Berdichevskiĭ BA; Kazeko NI; Ovchinnikov AA
    Urol Nefrol (Mosk); 1994; (2):16-9. PubMed ID: 8016997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of lipid peroxidation and activity of sympathetic nervous system in patients with chronic calculous pyelonephritis].
    Oskolkov SA; Zhmurov VA; Tverdoĭ VE; Arshakian GG; Zhmurov DV; Siniaev EA
    Urologiia; 2014; (3):8-12. PubMed ID: 25211919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipids content in renal tissue membranes in patients with urolithiasis and secondary pyelonephritis].
    Kazeko NI; Zhmurov VA; Borovskiĭ AA; Veshkurtsev VV; Khvan OV
    Urologiia; 2005; (5):56-8. PubMed ID: 16281843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Structural-functional damage to cellular membranes in deficiency of vitamins A, E, B2, B6, PP in children with calculous pyelonephritis].
    Atadzhanov UZh; Utegenov NU
    Urologiia; 2003; (1):35-41. PubMed ID: 12621965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The dynamic level of beta 2-microglobulin, the basic lipid peroxidation indices and middle molecules in the blood and urine in patients with acute calculous pyelonephritis against a background of endovascular helium-neon laser therapy].
    Safafov RM; Ianenko EK; Nikitinskaia LP; Golovanov SA; Drozhzheva VV; Kon'kova TA; Danilkov AP
    Urol Nefrol (Mosk); 1997; (1):11-3. PubMed ID: 9123656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
    Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I
    Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disturbances of lipid exchange and peroxidation system in patients with chronic pyelonephritis].
    Rudichenko EV; Antoniuk MV; Gvozdenko TA
    Klin Med (Mosk); 2006; 84(5):54-8. PubMed ID: 16827282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between immunogenic markers with metabolic processes in chronic pyelonephritis].
    Zhmurov VA; Oskolkov SA; Malishevskiĭ MV; Sazonova EV; Mel'nikov AA
    Urologiia; 2000; (3):9-13. PubMed ID: 11186718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Functional destabilization of the cell membranes in the pathogenesis of opisthorchiasis].
    Nalobin AV; Zhmurov VA; Nalobin VA; Liaĭkht EI
    Med Parazitol (Mosk); 1991; (2):13-5. PubMed ID: 2067485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The characteristics of the membrane-destabilizing mechanisms in chronic suppurative and suppurative-polypous sinusitis in children].
    Tarasov DI; Lazarev VN; Skriabin AS; Balandina EK
    Vestn Otorinolaringol; 1996; (1):32-4. PubMed ID: 8714049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinico-diagnostic evaluation of changes in ATPase activity, lipid peroxidation and stability of red cell membranes in patients suffering from hemorrhagic fever with renal syndrome].
    Ibragimova LA; Fazlyeva RM
    Ter Arkh; 2000; 72(11):21-4. PubMed ID: 11270949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of laser therapy and its combination with essentiale on the course of stable stenocardia, lipid peroxidation and the antioxidant protection of the erythrocyte membranes].
    Braslavskaia AP
    Lik Sprava; 1993; (10-12):72-4. PubMed ID: 8030314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative effectiveness of fluoroquinolones and beta-lactams in the complex therapy of patients with chronic pyelonephritis].
    Tverdoĭ VE; Oskolkov SA; Zhmurov VA; Petrova IuA; Oborotova NV
    Urologiia; 2012; (4):8-12. PubMed ID: 23116015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.